Fraud discovered in big Alzheimer’s study, but the mainstream still ignores Bredesen’s Breakthroughs

6 Comments

Not only have billions of dollars gone down the toilet in failed Big Pharma pills that target the amyloid of Alzheimer’s disease, but now we know fraudulent data photos were published in one of the most seminal rat studies of this disease. The fraud, at the time, convinced most researchers (and all NIH grant controllers) that amyloid CAUSES Alzheimer’s dementia.

BAMP! Wrong answer.

All of Big Pharma’s Alzheimer’s anti-amyloid pills have failed miserably for many years, yet this failed paradigm of amyloid-as-cause of the disease continues to suck every dollar of grant money away from researchers like Dale Bredesen who has actually published peer-reviewed studies of his success in REVERSING mild to moderate Alzheimer’s dementia.

The situation reminds me of how impossible it would be for a fiscal conservative like myself to convince a congresswoman/man (Democrat or Republican) that the FED’s power to print money is destroying the middle class and will lead to a central-bank digital currency that kills democracy, replacing it with a totalitarian oligarchy like the one promoted by the World Economic Forum and the CCP of China.

In the video linked here, Megyn Kelly interviews the whistleblowing scientist who discovered fraud in the rat study that pivoted mainstream researchers from doubting “amyloid-as-cause” to swallowing it whole without chewing.

As best I can tell, a bench tech slipped the fraud pictures into the paper without the lead scientist’s knowledge. This tech guy has a reputation of producing work that other labs cannot reproduce.

“Lies are the whole problem, Earthling.”

But far more important for my precious readers is this: at about 1:08:42 on the video, Kelly interviews Dale Bredesen, MD, the research scientist who has already reversed Alzheimer’s Disease in a fairly large number of patients.

They estimate that 45 million US Americans will soon have this unimaginably horrible disease. That means every single one of us needs to know about Dale Bredesen’s success because someone we know, if not we ourselves, will almost certainly be taken down by this cruel killer.

The number of Alzheimer’s deaths eclipses the COVID-19 pandemic, but beyond numbers, it’s difficult to imagine a more unbearable way to die than watching your mind, personality and memory slowly deteriorate until you cannot for the life of you recognize your spouse or kids.

Please take this disease seriously.

So mainstream medicine is clueless about Bredesen’s breakthrough work after they’ve wasted billions on failed monotherapy pills. And if an MD knows about Bredesen, odd are he/she criticizes him.

But how could any intelligent person be so rigidly devoted to denying the truth?

It’s somewhat simple. They demand to see an experimental design with double-blinded controls geared to test “one thing at a time,” (the Big Pharma monotherapy dogma).

By definition, the monotherapy approach cannot work when you’re dealing with a chronic disease that has dozens of mini-causes working together in synergistic combinations.

Alzheimer’s is an E pluribus unum disease — “from many, one.”

Modern monotherapy medicine is clueless to deal with such complexity. Instead it demands to live in the past and block progress with outdated standards of monotherapy experimental design.

But can’t Dr. Bredesen produce blinded controls and satisfy the mainstream?

No, not at all. Think about what he’s up against.

When altering lifestyle, diet, heavy exercise, carbohydrate toxicity ( for “type 2 diabetes of the brain”), fighting specific chronic infections like Herpes Simplex Virus, eliminating neurotoxins, and running large-spectrum blood analyses to discover and target each patient’s specific causes of Alz dementia, it is impossible to design a study with double-blinded controls, because…

For instance, how can Bredesen blind (hide from) a patient the fact that she is on a low carb diet testing her ketone levels daily and exercising heavily three or four times a week? And conversely, how do you hide from the controls the fact that they are not doing these things?

You can’t.

The test cohort and the control patients will know exactly which category they’re in. This makes all studies that are aimed against multi-factorial diseases such as Alzheimer’s, absolutely predestined by Big Pharma to fail and be viewed as worthless by mainstream doctors and their journal gatekeepers who have been educated for generations by Big Pharma reps, you know, those gregarious extroverts giving away free pens, free gadgets, and free lunch during their lectures on journal articles supporting their company’s big-hitting pills.

Meanwhile, to any rational mind not brainwashed for generations by Big Pharma, the controls they demand are actually present in the general populations of the world. They consist of vast numbers of people who are dying of (and with) Alzheimer’s disease. Not one of these “common-sense control” patients has had a reversal (or even a slowing) of symptoms once a well documented diagnosis of Alzheimer’s disease has been made.

So hey, if you’re having mental fog at all, even in you mid 40’s, ask your doc if you’re OK to experiment with a ketogenic diet for a month or two. And maybe do some vigorous cardio with it, if you’re able.

The keto diet alone will show you what a clear mind (burning ketones rather than just glucose) feels like. If you have chronic free-floating anxiety or mild depression, I predict it will largely vanish along with the brain fog.

Then you’ll have personal evidence (n=1) on the amazing Bredesen Protocol.

…

Keto Love,

Morrill Talmage Moorehead, MD

PS. Send this article to someone with a brilliant mind that you appreciate, perhaps someone who’s 40 years old or better.

Ending Alzheimer’s Disease

31 Comments

The End of Alzheimer’s, by Dale Bredesen, MD, is finally out. I’ve been waiting for this forever. All the details of his protocol are now available to the public!

This book may save your mind and the minds of your loved ones. Buy it. Read it. Loan it to your doctor. 🙂

Clinical studies using Bredesen’s ReCODE protocol are showing breakthrough results in patients with mild to moderate Alzheimer’s Disease as well as pre-Alzheimer’s. Over 200 patient success stories exist, many are breathtaking. In each case, the disease was well documented before treatment.

Bredesen’s ingenious basic science research on Alzheimer’s Disease has been published in peer-reviewed journals for 28 years, yet strangely his successful clinical protocol papers have received a cold shoulder from the medical establishment.

Is this because Bredesen is going after causes while mainstream medicine is interested only in masking symptoms? No. It may seem that way sometimes, but the truth is much more interesting.

It boils down to a rigid devotion to traditional experimental design which insists that each component of any therapy must be studied separately. Yes, rarely the medical gatekeepers will make an exception and study two medications simultaneously for certain diseases, but the moon has to be just right for such madness.

Historically this monotherapy approach has worked fairly well for diseases with single causes, but it creates a roadblock to clinical research on complex diseases such as Alzheimer’s.

Though the evidence against monotherapy for Alzheimer’s Disease is a billion-dollar wasteland of failed clinical trials, medical authorities cling to their linear way of thinking, blindly following the sacred tradition of scientific fundamentalists throughout history who have uniformly obstructed all major paradigm shifts with their flawed scientific beliefs and assumptions.

In the case of Alzheimer’s Disease, the belief is simple: if you don’t isolate one thing at a time, you’ll never know exactly what that one thing does in isolation.

Brilliant deduction. The assumption, though, is that knowing what each thing does in isolation should always be the ultimate goal of science and medicine.

This is narrow reductionism – dissecting a thing with the mistaken belief that answers can only be found in the parts.

But as Emerson said, “Foolish consistency is the hobgoblin of small minds.” Sometimes the destruction of a forest cannot be prevented by focusing only on the trees.

In medical science, understanding a system as a functioning whole in both disease and health is more central than reductionism to the overall goal, which is saving patients’ lives.

Bredesen’s protocol is doing exactly that, as documented in peer-reviewed journals.

Disease complexity is why monotherapy experimental design has made no significant progress against Alzheimer’s Disease. This is a disease with at least 36 to 50 different “things” that can go wrong in various combinations that cause the mind to fail. The numbers and mixes of partial causes differ from one patient to the next, but three broad categories have emerged: Inflammatory, atrophic and toxic.

All three produce the same pathognomonic plaques and tangles under light microscopy, so pathologists consider Alzheimer’s a single disease, and drug companies target amyloid with their failed monotherapies.

It’s not as simple as they assume.

Clinically testing Bredesen’s therapies for each of the 36 to 50 causal elements in isolation, if it were possible and fundable (which it’s not), would take many decades and result in falsely negative and/or equivocal outcomes. This is because:

1. Each component of Bredesen’s protocol reverses only a small fraction of the 36 to 50 disease-promoting processes, and those processes are not uniformly distributed in the Alzheimer’s population. So any one of them tested in isolation would not likely have enough overall effect to achieve statistical significance. It’s like firing a shotgun one pellet at a time expecting to stop a serial killer in your bedroom. Stupid, right? Bredesen’s total protocol (tailored to each patient with lab tests) is needed to reverse mild to moderate Alzheimer’s Disease.

2. The synergistic effects of therapeutic components are foolishly eliminated by linear monotherapy-biased experimental design. Keep red and green separate and you won’t discover yellow.

Ignoring Bredesen’s work, as the orthodox mainstream currently prefers to do, is the moral equivalent of physical abuse to Alzheimer’s patients.

The mechanisms producing Alzheimer’s Disease take decades to produce symptoms, so when memory loss or difficulty with word-finding shows up, the disease has already been silently progressing for decades. The earlier you treat it, the better your chances for complete reversal. The worst thing you can do is wait for early symptoms to progress.

If you know anyone with subjective cognitive decline or mild to moderate Alzheimer’s disease, do them the biggest favor of their lives. Read Dale Bredesen’s breakthrough book for yourself and share your knowledge. Maybe the person you care about won’t be fooled by the supercilious, confident, sophisticated-sounding monotherapy zombies who feel they must watch their patients die while waiting for a prescription pill from a drug company.

Sorry, that sounds harsh. But people are dying in the worst imaginable hell while a scientifically documented breakthrough is ignored. It’s astonishing!

The problem is that most MD’s are too busy to read extensively and learn how to distinguish good science from unsubstantiated claims. So they blindly listen to authorities who have the power to take away their licenses.

In medical school, we studied our lecture notes and books with virtually no impetus to learn to critically evaluate journal articles. We had one brief class in statistics.

Anyway, here’s a video interview of Dale Bredesen discussing the groundbreaking, unprecedented results of his ReCODE protocol. Enjoy!

Learning the truth is always fun, and…

“It’s fun to have fun, but you’ve got to know how.” – Dr. Seuss.

Morrill Talmage Moorehead, MD
Retired Pathologist, science fiction writer, and novel content editor.

(I have no conflicts of interest to report and no personal acquaintance with Dr. Bredesen.)